Logo Logo
Hilfe
Hilfe
Switch Language to English

Fabritius, Matthias P.; Hartmann, Fabian; Seidensticker, Ricarda; Pech, Maciej; Powerski, Maciej; Grosu, Sergio; Maurus, Stefan; Todica, Andrei; Ilhan, Harun; Omari, Jazan; Damm, Robert; Grosser, Oliver; Albers, Josefine; Ricke, Jens und Seidensticker, Max (2021): Liver Function Changes After Technetium-99m-Macroaggregated Albumin Administration and Their Predictive Value Regarding Hepatotoxicity in Patients Undergoing Yttrium-90-Radioembolization. In: Anticancer Research, Bd. 41, Nr. 1: S. 437-444

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Background/Aim: Intraarterial Technetium-99m-Macroaggregated Albumin (Tc-99(m)-MAA) administration is an established method to predict particle distribution prior to radioembolization. This study aimed to analyse the impact of intraarterial administration of Tc-99(m)-MAA on changes in liver-specific laboratory parameters and to assess whether such changes are associated with post-radioembolization hepatotoxicity. Patients and Methods: A total of 202 patients treated with radioembolization received prior mapping angiography with Tc-99(m)-MAA administration. All patients underwent clinical and laboratory examinations, including liver-specific parameters at certain times before and after mapping angiographyl Tc-99(m)-MAA administration, as well as before radioembolization and during follow-up. Results: Bilirubin increased temporarily after Tc-99(m)-MAA administration (p<0.001), but was not clinically relevant, and returned close to the initial value before radioembolization. These changes showed no association with subsequent postradioembolic hepatotoxicity or shortened overall survival. Conclusion: Tc-99(m)-MAA administration results in a significant, however, not clinically relevant transient increase in bilirubin levels, which does not provide a predictive value for subsequent radioembolization outcome or postradioembolic hepatotoxicity.

Dokument bearbeiten Dokument bearbeiten